Zacks Research Predicts Itron’s Q2 Earnings (NASDAQ:ITRI)

Itron, Inc. (NASDAQ:ITRI) – Investment analysts at Zacks Research dropped their Q2 2026 earnings estimates for Itron in a report released on Tuesday, May 19th. Zacks Research analyst Team now expects that the scientific and technical instruments company will post earnings per share of $1.31 for the quarter, down from their previous forecast of $1.44. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Itron’s current full-year earnings is $6.01 per share. Zacks Research also issued estimates for Itron’s Q3 2026 earnings at $1.52 EPS, FY2026 earnings at $5.97 EPS and Q1 2028 earnings at $1.77 EPS.

Itron (NASDAQ:ITRI) last announced its earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.26 by $0.23. Itron had a net margin of 12.31% and a return on equity of 19.54%. The company had revenue of $586.98 million during the quarter, compared to analysts’ expectations of $572.04 million. During the same period last year, the company posted $1.52 earnings per share. The business’s revenue for the quarter was down 3.3% on a year-over-year basis. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS.

Several other analysts have also recently commented on ITRI. Raymond James Financial assumed coverage on shares of Itron in a report on Tuesday, April 21st. They set an “underperform” rating for the company. Stephens restated an “overweight” rating and set a $130.00 price target on shares of Itron in a report on Wednesday. Guggenheim set a $155.00 price target on shares of Itron in a report on Friday, February 13th. Weiss Ratings restated a “hold (c)” rating on shares of Itron in a report on Friday, May 8th. Finally, Roth Mkm restated a “buy” rating and set a $136.00 price target on shares of Itron in a report on Wednesday, April 29th. Eight research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Itron presently has a consensus rating of “Moderate Buy” and an average target price of $131.22.

Itron Stock Performance

Shares of ITRI opened at $81.35 on Thursday. Itron has a one year low of $77.77 and a one year high of $142.00. The company has a 50-day moving average of $88.85 and a two-hundred day moving average of $94.73. The stock has a market cap of $3.61 billion, a price-to-earnings ratio of 12.97, a PEG ratio of 0.68 and a beta of 1.35. The company has a debt-to-equity ratio of 0.97, a current ratio of 2.66 and a quick ratio of 2.24.

Insider Buying and Selling at Itron

In related news, SVP John F. Marcolini sold 1,074 shares of the firm’s stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $100.17, for a total transaction of $107,582.58. Following the transaction, the senior vice president owned 25,838 shares of the company’s stock, valued at approximately $2,588,192.46. This trade represents a 3.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Donald L. Reeves III sold 519 shares of the firm’s stock in a transaction that occurred on Wednesday, February 25th. The shares were sold at an average price of $97.84, for a total transaction of $50,778.96. Following the transaction, the senior vice president directly owned 29,951 shares in the company, valued at approximately $2,930,405.84. The trade was a 1.70% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 10,331 shares of company stock valued at $1,016,328 in the last 90 days. Corporate insiders own 1.77% of the company’s stock.

Hedge Funds Weigh In On Itron

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ITRI. Impax Asset Management Group plc raised its position in Itron by 127.3% during the third quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company’s stock valued at $197,153,000 after acquiring an additional 890,040 shares in the last quarter. Norges Bank bought a new position in shares of Itron in the fourth quarter valued at approximately $63,990,000. Soros Fund Management LLC bought a new position in shares of Itron in the fourth quarter valued at approximately $34,843,000. Millennium Management LLC raised its position in shares of Itron by 269.3% in the fourth quarter. Millennium Management LLC now owns 506,867 shares of the scientific and technical instruments company’s stock valued at $47,068,000 after purchasing an additional 369,617 shares during the period. Finally, Merewether Investment Management LP raised its position in shares of Itron by 1,552.7% in the second quarter. Merewether Investment Management LP now owns 300,787 shares of the scientific and technical instruments company’s stock valued at $39,593,000 after purchasing an additional 282,587 shares during the period. Institutional investors own 96.19% of the company’s stock.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.